KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Short-term Investments: 2018-2025

Historic Short-term Investments for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $49.4 million.

  • Twist Bioscience's Short-term Investments fell 1.36% to $49.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.4 million, marking a year-over-year decrease of 1.36%. This contributed to the annual value of $49.4 million for FY2025, which is 1.36% down from last year.
  • Latest data reveals that Twist Bioscience reported Short-term Investments of $49.4 million as of Q3 2025, which was down 0.05% from $49.4 million recorded in Q2 2025.
  • Twist Bioscience's Short-term Investments' 5-year high stood at $166.2 million during Q1 2022, with a 5-year trough of $12.0 million in Q3 2021.
  • In the last 3 years, Twist Bioscience's Short-term Investments had a median value of $49.7 million in 2023 and averaged $51.1 million.
  • Per our database at Business Quant, Twist Bioscience's Short-term Investments tumbled by 93.87% in 2021 and then soared by 949.37% in 2022.
  • Quarterly analysis of 5 years shows Twist Bioscience's Short-term Investments stood at $110.2 million in 2021, then climbed by 10.70% to $122.0 million in 2022, then plummeted by 63.23% to $44.9 million in 2023, then climbed by 10.14% to $49.4 million in 2024, then decreased by 1.36% to $49.4 million in 2025.
  • Its Short-term Investments stands at $49.4 million for Q3 2025, versus $49.4 million for Q2 2025 and $46.7 million for Q1 2025.